19 Results for "

Cabozantinib-S-

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "Cabozantinib-S-" in MCE Product Catalog:

58
58 Publications Verification
Cat. No.: HY-13016
CAS No.: 849217-68-1
Purity:  99.96%
Synonyms: XL184; BMS-907351
Research Areas:  

Cancer

Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035, and 1.3 nM, respectively. Cabozantinib displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3 (IC50=4.6, 5.2, 7, 14.3, and 11.3 nM, respectively). Cabozantinib shows antiangiogenic activity. Cabozantinib disrupts tumor vasculature and promotes tumor and endothelial cell apoptosis .
57
57 Cited Publications
Cat. No.: HY-12044
CAS No.: 1140909-48-3
Purity:  99.90%
Synonyms: XL184 S-malate; BMS-907351 S-malate
Target:  

VEGFR Apoptosis

Research Areas:  

Cancer

Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Cat. No.: HY-13016S
CAS No.: 1802168-46-2
Purity:  98.14%
Synonyms: XL184-d6; BMS-907351-d6
Cabozantinib-d6 is the deuterium labeled Cabozantinib. Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively .
Cat. No.: HY-13016R
CAS No.: 849217-68-1
Synonyms: XL184 (Standard); BMS-907351 (Standard)
Cabozantinib (Standard) is the analytical standard of Cabozantinib. This product is intended for research and analytical applications. Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035, and 1.3 nM, respectively. Cabozantinib displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3 (IC50=4.6, 5.2, 7, 14.3, and 11.3 nM, respectively). Cabozantinib shows antiangiogenic activity. Cabozantinib disrupts tumor vasculature and promotes tumor and endothelial cell apoptosis .
Cat. No.: HY-13016S1
CAS No.: 1802168-53-1
Synonyms: XL184-d4; BMS-907351-d4
Cabozantinib-d4 is deuterium labeled Cabozantinib. Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Cat. No.: HY-13016A
CAS No.: 1817759-42-4
Synonyms: XL184 hydrochloride; BMS-907351 hydrochloride
Research Areas:  

Cancer

Cabozantinib hydrochloride is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035 and 1.3 nM, respectively. Cabozantinib hydrochloride displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3 (IC50=4.6, 5.2, 7, 14.3, and 11.3 nM, respectively). Cabozantinib hydrochloride shows antiangiogenic activity. Cabozantinib hydrochloride disrupts tumor vasculature and promotes tumor and endothelial cell apoptosis .
Cat. No.: HY-45124
CAS No.: 849217-50-1
3-Fluoro-desmethyl-cabozantinib is an BCL6 ligand that can be used in the synthesis of PROTACs, such as SJF-8240 (HY-123961) . 3-Fluoro-desmethyl-cabozantinib is also a p38α ligand that can be used to synthesize PROTACs, such as SJFα (HY-114404) .
Cat. No.: HY-109084A
Synonyms: CT-707 tetrahydrochloride
Target:  

FAK

Research Areas:  

Cancer

Conteltinib tetrahydrochloride (CT-707 tetrahydrochloride) is the tetrahydrochloride salt form of Conteltinib (HY-109084). Conteltinib tetrahydrochloride is the inhibitor for FAK (IC50=1.6 nM), ALK, and Pyk2. Conteltinib tetrahydrochloride exhibits a synergistic anti-tumor efficacy with Cabozantinib (HY-13016) .
Cat. No.: HY-12044R
CAS No.: 1140909-48-3
Synonyms: XL184 S-malate (Standard); BMS-907351 S-malate (Standard)
Research Areas:  

Cancer

Cabozantinib (S-malate) (Standard) is the analytical standard of Cabozantinib (S-malate). This product is intended for research and analytical applications. Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Cat. No.: HY-176385
CAS No.: 2230826-10-3
3-Fluoro-desmethyl-cabozantinib-C3-O-C3-PEG-acid is a target protein ligand-linker conjugate that incorporates a ligand for c-Met (HY-451241) and a PROTAC linker (HY-W442078), which recruits E3 ligases. 3-Fluoro-desmethyl-cabozantinib-C3-O-C3-PEG-acid can be used in the synthesis of PROTACs, such as SJF-8240 (HY-123961) .
Cat. No.: HY-100833R
CAS No.: 251349-54-9
Research Areas:  

Infection

Cabozantinib (S-malate) (Standard) is the analytical standard of Cabozantinib (S-malate). This product is intended for research and analytical applications. Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Cat. No.: HY-10338A
CAS No.: 1226999-07-0
Target:  

c-Met/HGFR VEGFR

Research Areas:  

Cancer

Foretinib phosphate is an orally bioavailable small molecule with potential anti-tumor activity. Foretinib phosphate can selectively inhibit hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), thereby potentially inhibiting tumor angiogenesis, tumor cell proliferation and metastasis. Foretinib phosphate shows different anti-cancer activity from cabozantinib in lung cancer cells and has stronger inhibitory effects on targets such as MEK1/2, FER and AURKB .
Cat. No.: HY-W706452
Synonyms: XL184-d4 S-malate; BMS-907351-d4 S-malate
Cabozantinib-d4 (S-malate) (XL184-d4 (S-malate); BMS-907351-d4 (S-malate)) is the deuterium labeled Cabozantinib (S-malate) (HY-12044). Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Cat. No.: HY-Z1053
CAS No.: 748707-58-6
Target:  

Drug Intermediate

Research Areas:  

Others

Cabozantinib impurity 8 is an impurity of Cabozantinib (HY-13016).
Cat. No.: HY-Z2093
CAS No.: 1247859-37-5
Target:  

Drug Intermediate

Research Areas:  

Others

Cabozantinib impurity 7 is an impurity of Cabozantinib (HY-13016).
Cat. No.: HY-Z2199
CAS No.: 918642-61-2
Target:  

Drug Intermediate

Research Areas:  

Others

Cabozantinib impurity 1 is an impurity of Cabozantinib (HY-13016).
Cat. No.: HY-Z1053R
CAS No.: 748707-58-6
Research Areas:  

Others

Cabozantinib impurity 8 (Standard) is the analytical standard of Cabozantinib impurity 8 (HY-Z1053). This product is intended for research and analytical applications.
Cat. No.: HY-Z2093R
CAS No.: 1247859-37-5
Target:  

Reference Standards

1-((3-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid (Cabozantinib Impurity) (Standard) is the analytical standard of 1-((3-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid (Cabozantinib Impurity). This product is intended for research and analytical applications.
Cat. No.: HY-Z2199R
CAS No.: 918642-61-2
Target:  

Reference Standards

1-((2-fluorophenyl)carbamoyl)cyclopropanecarboxylic acid (Cabozantinib Impurity) (Standard) is the analytical standard of 1-((2-fluorophenyl)carbamoyl)cyclopropanecarboxylic acid (Cabozantinib Impurity). This product is intended for research and analytical applications.
  • 1